99% Savings - Buy Just @1 Rs X
Tocef CV 50 Mg/31.25 Mg Dry Syrup, a prescription drug, is manufactured in various forms such as Syrup. Other than this, Tocef CV 50 Mg/31.25 Mg Dry Syrup has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Tocef CV 50 Mg/31.25 Mg Dry Syrup. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Tocef CV 50 Mg/31.25 Mg Dry Syrup can also lead to other problems, which have been listed below. Such side effects of Tocef CV 50 Mg/31.25 Mg Dry Syrup normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Tocef CV 50 Mg/31.25 Mg Dry Syrup's effect is Mild during pregnancy and Moderate for lactating mothers. Warnings related to Tocef CV 50 Mg/31.25 Mg Dry Syrup's effects on the liver, heart and kidney, if any, have been listed below.
Tocef CV 50 Mg/31.25 Mg Dry Syrup is contraindicated in people with pre-existing medical conditions like Jaundice as it can result in adverse effects. Some other conditions that can be affected by Tocef CV 50 Mg/31.25 Mg Dry Syrup are listed in the contraindications section below.
Drug reaction of Tocef CV 50 Mg/31.25 Mg Dry Syrup with other medicines has been reported. See below for a complete list.
You should also be aware that Tocef CV 50 Mg/31.25 Mg Dry Syrup is safe while driving, and is addiction.
Tocef CV 50 Mg/31.25 Mg Dry Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Is the use of Tocef CV 50 Mg/31.25 Mg Dry Syrup safe for pregnant women?
Pregnant women can consume [medicine]. Though Tocef Cv has mild side effects when taken during pregnany
Is the use of Tocef CV 50 Mg/31.25 Mg Dry Syrup safe during breastfeeding?
Breastfeeding women may feel side effects of Tocef Cv. If you see any side effects, stop taking Tocef Cv immediately and talk to your doctor. Take Tocef Cv again, only after your doctor's advice.
What is the effect of Tocef CV 50 Mg/31.25 Mg Dry Syrup on the Kidneys?
There can be some harmful effects on your kidneys after taking Tocef Cv. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Tocef CV 50 Mg/31.25 Mg Dry Syrup on the Liver?
There may be an adverse effect on the liver after taking Tocef Cv. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Tocef CV 50 Mg/31.25 Mg Dry Syrup on the Heart?
Side effects of Tocef Cv rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Tocef CV 50 Mg/31.25 Mg Dry Syrup unless your doctor advises you to do so -
Is this Tocef CV 50 Mg/31.25 Mg Dry Syrup habit forming or addictive?
Forming a habit of Tocef CV 50 Mg/31.25 Mg Dry Syrup has not been reported.
Interaction between Food and Tocef CV 50 Mg/31.25 Mg Dry Syrup
It is safe to take Tocef CV 50 Mg/31.25 Mg Dry Syrup with food.
Interaction between Alcohol and Tocef CV 50 Mg/31.25 Mg Dry Syrup
It is difficult to say anything about the effect of Tocef CV 50 Mg/31.25 Mg Dry Syrup and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311